Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Psychoneuroendocrinology. 2015 Feb 16;55:94–101. doi: 10.1016/j.psyneuen.2015.02.004

Table 1. Demographic Information and Clinical Characteristics.

Variable No MDD outcome (n = 58) MDD outcome (n = 31) Statistics p value
Age at T1, M (SD) 13.37 (1.37) 12.39 (1.48) t(87) = 3.110 0.003
CDI-S at T1, M (SD) 1.52 (1.54) 2.45 (2.84) t(87) = 2.020 0.046
Number of Rsk girls 18/58 24/31 χ2(1, N = 89) = 17.442 < 0.001
Ethnicity (% caucasian) 65.5 80.6 x2(1,89) = 2.236 0.135
Age of menstration, M (SD) 11.87 (1.12) 11.33 (0.78) t(41) = 1.524 0.135
Tanner stage at T1 3.45 (0.91) 3.15 (0.96) t(87) = 1.468 0.146
BMI, M (SD) 19.68 (2.87) 20.14 (2.82) t(75) = .668 0.506
Time of first cortisol collection (minutes from midnight), M (SD) 773.53 (168.70) 815.81 (167.60) t(87) = 1.129 0.262
Medication usage at T1, % 4 6.50 x2(1,89) = .425 0.608
Cortisol reactivity, M (SD) 30.21 (78.83) 51.96 (100.05) t(87) = 1.127 0.263
Cortisol recovery, M (SD) -22.52 (32.03) -19.84 (71.09) t(87) = .245 0.807

Note: Standard deviations are presented in parentheses. MDD = Major Depressive Disorder; No MDD outcome = participants who did develop major depressive disorder prior to age 21; MDD outcome = participants who did develop major depressive disorder prior to age 21; T1 = 1st visit to the laboratory (baseline); CDI = Children's Depression Inventory - Short Form.